First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography

Int J Cardiol. 2013 Oct;168(4):4490-1. doi: 10.1016/j.ijcard.2013.06.127. Epub 2013 Jul 24.

Authors

Carmelo Grasso¹, Guilherme F Attizzani, Martina Patané, Yohei Ohno, Davide Capodanno, Corrado Tamburino

Affiliation

¹ Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy.

PMID: 23890924
DOI: 10.1016/j.ijcard.2013.06.127

No abstract available

Keywords: Bioresorbable vascular scaffold; In-stent restenosis; Optical coherence tomography.

Publication types

Case Reports
Letter

MeSH terms

Absorbable Implants
Coronary Restenosis / therapy*
Drug-Eluting Stents*
Everolimus
Humans
Male
Middle Aged
Prosthesis Design
Sirolimus / administration & dosage
Sirolimus / analogs & derivatives*
Tissue Scaffolds*
Tomography, Optical Coherence*
Treatment Failure

Substances

Everolimus
Sirolimus